Managing scientific, technical and regulatory innovation in regulated bioanalysis: a discussion paper from the European Bioanalysis Forum

European Bioanalysis Forum recommendation: scientific validation of quantification by accelerator mass spectrometry

(2012) David Higton et al.   Bioanalysis

Conference Report: The 3rd EBF Focus Meeting: ‘Hatching’ – emerging technologies approaching the regulated bioanalysis laboratory

(2012) Jessica Dijksman et al.   Bioanalysis

Conference Report: ‘Large Meets Small’: connecting the bioanalytical community around peptide and protein bioanalysis with LC–MS(/MS)

(2012) Philip Timmerman et al.   Bioanalysis

Confirmation of no impact from different anticoagulant counter ions on bioanalytical method

(2012) Annik Bergeron et al.   Bioanalysis

Anticoagulant counter ion impact on bioanalytical LC–MS/MS assays: results from discussions and experiments within the European Bioanalysis Forum

(2011) Carl Johan Sennbro et al.   Bioanalysis

Anticoagulant counter ion impact on bioanalytical LC–MS/MS assay performance: additional validation required?

(2011) Carl Johan Sennbro et al.   Bioanalysis

AMS method validation for quantitation in pharmacokinetic studies with concomitant extravascular and intravenous administration

(2011) Graham Lappin et al.   Bioanalysis

Best practices in a tiered approach to metabolite quantification: views and recommendations of the European Bioanalysis Forum

(2010) Philip Timmerman et al.   Bioanalysis

Workshop Report and Follow-Up—AAPS Workshop on Current Topics in GLP Bioanalysis: Assay Reproducibility for Incurred Samples—Implications of Crystal City Recommendations

(2009) Douglas M. Fast et al.   AAPS Journal

Incurred sample reproducibility: views and recommendations by the European Bioanalysis Forum

(2009) Philip Timmerman et al.   Bioanalysis